Magnetic resonance cholangiogram patterns and clinical profiles of ketamine-related cholangiopathy in drug users

Recreational use of inhalational ketamine is emerging as a major global social and health issue [1,2]. While ketamine, a N-methyl D-aspartate receptor antagonist, has medical uses in anesthesia and chronic pain control, its highly addictive nature has led to a massive increase in recreational consumption worldwide. Due to the ease of production and low cost, the non-medical use of ketamine is especially increasing in East and South East Asia, with its lifetime prevalence in the general population ranging from 0.3% to 2.0% [3], comprising up to 39.7% of total recreational drugs users in these regions [4].
Source: Journal of Hepatology - Category: Gastroenterology Authors: Source Type: research